10,502
Views
0
CrossRef citations to date
0
Altmetric
Review

LSD1: Biologic Roles and Therapeutic Targeting

&
Pages 1103-1116 | Received 25 Jan 2016, Accepted 27 May 2016, Published online: 01 Aug 2016

References

  • Kouzarides T . Chromatin modifications and their function . Cell128 ( 4 ), 693 – 705 ( 2007 ).
  • H⊘jfeldt JW , AggerK , HelinK . Histone lysine demethylases as targets for anticancer therapy . Nat. Rev. Drug Discov.12 ( 12 ), 917 – 930 ( 2013 ).
  • Shi YY , LanF , MatsonCet al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 . Cell119 ( 7 ), 941 – 953 ( 2004 ).
  • Tong JK , HassigCA , SchnitzlerGR , KingstonRE , SchreiberSL . Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex . Nature395 ( 6705 ), 917 – 921 ( 1998 ).
  • Humphrey GW , WangY , RussanovaVRet al. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1 . J. Biol. Chem.276 ( 9 ), 6817 – 6824 ( 2001 ).
  • You A , TongJK , GrozingerCM , SchreiberSL . CoREST is an integral component of the CoREST–human histone deacetylase complex . Proc. Natl Acad. Sci. USA98 ( 4 ), 1454 – 8 ( 2001 ).
  • Hakimi MA , DongY , LaneWS , SpeicherDW , ShiekhattarR . A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes . J. Biol. Chem.278 ( 9 ), 7234 – 7239 ( 2003 ).
  • Shi Y , SawadaJ , SuiGet al. Coordinated histone modifications mediated by a CtBP co-repressor complex . Nature422 ( 6933 ), 735 – 738 ( 2003 ).
  • Shi YJY , MatsonC , LanF , IwaseS , BabaT , ShiYJY . Regulation of LSD1 histone demethylase activity by its associated factors . Mol. Cell19 ( 6 ), 857 – 864 ( 2005 ).
  • Wang Y , ZhangH , ChenYet al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer . Cell138 ( 4 ), 660 – 672 ( 2009 ).
  • Nakamura T , MoriT , TadaSet al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation . Mol. Cell10 ( 5 ), 1119 – 1128 ( 2002 ).
  • Forneris F , BindaC , AdamoA , BattaglioliE , MatteviA . Structural basis of LSD1-CoREST selectivity in histone H3 recognition . J. Biol. Chem.282 ( 28 ), 20070 – 20074 ( 2007 ).
  • Lee MG , WynderC , CoochN , ShiekhattarR . An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation . Nature437 ( 7057 ), 432 – 435 ( 2005 ).
  • Lee MG , WynderC , BocharDA , HakimiMA , CoochN , ShiekhattarR . Functional interplay between histone demethylase and deacetylase enzymes . Mol. Cell. Biol.26 ( 17 ), 6395 – 6402 ( 2006 ).
  • Lan F , CollinsRE , De CegliRet al. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression . Nature448 ( 7154 ), 718 – 722 ( 2007 ).
  • Rivero S , Ceballos-ChávezM , BhattacharyaSS , ReyesJC . HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition . Oncogene34 ( 41 ), 5264 – 5276 ( 2015 ).
  • Upadhyay G , ChowdhuryAH , VaidyanathanB , KimD , SalequeS . Antagonistic actions of Rcor proteins regulate LSD1 activity and cellular differentiation . Proc. Natl Acad. Sci. USA111 ( 22 ), 8071 – 8076 ( 2014 ).
  • Barrios ÁP , GómezAV , SáezJEet al. Differential properties of transcriptional complexes formed by the CoREST family . Mol. Cell. Biol.34 ( 14 ), 2760 – 2770 ( 2014 ).
  • Ouyang J , ShiY , ValinA , XuanY , GillG . Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex . Mol. Cell34 ( 2 ), 145 – 154 ( 2009 ).
  • Geiss-Friedlander R , MelchiorF . Concepts in sumoylation: a decade on . Nat. Rev. Mol. Cell Biol.8 ( 12 ), 947 – 956 ( 2007 ).
  • Tsai M-C , ManorO , WanYet al. Long noncoding RNA as modular scaffold of histone modification complexes . Science329 ( 5992 ), 689 – 693 ( 2010 ).
  • Lynch JT , HarrisWJ , SomervailleTC . LSD1 inhibition: a therapeutic strategy in cancer?Expert Opin. Ther. Targets16 ( 12 ), 1239 – 1249 ( 2012 ).
  • Sun G , YeP , MuraiKet al. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells . Nat. Commun.2 , 529 ( 2011 ).
  • Han X , GuiB , XiongCet al. Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development . Mol. Cell55 ( 3 ), 482 – 494 ( 2014 ).
  • Wu Y , WangY , YangXHet al. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells . Cell Rep.5 ( 1 ), 224 – 236 ( 2013 ).
  • Culhane JC , ColePA . LSD1 and the chemistry of histone demethylation . Curr. Opin. Chem. Biol11 ( 5 ), 561 – 568 ( 2007 ).
  • Aravind L , IyerLM . The SWIRM domain: a conserved module found in chromosomal proteins points to novel chromatin-modifying activities . Genome Biol.3 ( 8 ), research0039.1–research0039.7 ( 2002 ).
  • Stavropoulos P , BlobelG , HoelzA . Crystal structure and mechanism of human lysine-specific demethylase-1 . Nat. Struct. Mol. Biol.13 ( 7 ), 626 – 632 ( 2006 ).
  • Fang R , ChenF , DongZet al. LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation . Mol. Cell49 ( 3 ), 558 – 570 ( 2013 ).
  • Forneris F , BindaC , VanoniMA , BattaglioliE , MatteviA . Human histone demethylase LSD1 reads the histone code . J. Biol. Chem.280 ( 50 ), 41360 – 41365 ( 2005 ).
  • Polticelli F , BasranJ , FasoCet al. Lys300 plays a major role in the catalytic mechanism of maize polyamine oxidase . Biochemistry44 ( 49 ), 16108 – 16120 ( 2005 ).
  • Yang M , GockeCB , LuoXet al. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase . Mol. Cell23 ( 3 ), 377 – 387 ( 2006 ).
  • Baron R , VelloreN . LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition . Proc. Natl Acad. Sci. USA109 ( 31 ), 12509 – 12514 ( 2012 ).
  • Yoneyama M , TochioN , UmeharaTet al. Structural and functional differences of SWIRM domain subtypes . J. Mol. Biol.369 ( 1 ), 222 – 238 ( 2007 ).
  • Metzger E , WissmannM , YinNet al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription . Nature437 ( 7057 ), 436 – 439 ( 2005 ).
  • Yang M , CulhaneJC , SzewczukLMet al. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation . Nat. Struct. Mol. Biol.14 ( 6 ), 535 – 539 ( 2007 ).
  • Forneris F , BindaC , Dall’AglioA , FraaijeMW , BattaglioliE , MatteviA . A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1 . J. Biol. Chem.281 ( 46 ), 35289 – 35295 ( 2006 ).
  • Burg JM , GonzalezJJ , MaksimchukKR , McCaffertyDG . Lysine-specific demethylase 1A (KDM1A/LSD1): product recognition and kinetic analysis of full-length histones . Biochemistry55 ( 11 ), 1652 – 1662 ( 2015 ).
  • Huang J , SenguptaR , EspejoABet al. p53 is regulated by the lysine demethylase LSD1 . Nature449 ( 7158 ), 105 – 108 ( 2007 ).
  • Kontaki H , TalianidisI . Lysine methylation regulates E2F1-induced cell death . Mol. Cell39 ( 1 ), 152 – 160 ( 2010 ).
  • Wang J , HeviS , KurashJKet al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation . Nat. Genet.41 ( 1 ), 125 – 129 ( 2009 ).
  • Wang J , ScullyK , ZhuXet al. Opposing LSD1 complexes function in developmental gene activation and repression programmes . Nature446 ( 7138 ), 882 – 887 ( 2007 ).
  • Macfarlan TS , GiffordWD , AgarwalSet al. Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A . Genes Dev.25 ( 6 ), 594 – 607 ( 2011 ).
  • Adamo A , SeséB , BoueSet al. LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells . Nat. Cell Biol.13 ( 6 ), 652 – 659 ( 2011 ).
  • Foster CT , DoveyOM , LezinaLet al. Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability . Mol. Cell. Biol.30 ( 20 ), 4851 – 4863 ( 2010 ).
  • Takeuchi MM , FuseY , WatanabeMet al. LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2 . Proc. Natl Acad. Sci. USA112 ( 45 ), 13922 – 13927 ( 2015 ).
  • Thambyrajah R , MazanM , PatelRet al. GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1 . Nat. Cell Biol.18 ( 1 ), 21 – 32 ( 2015 ).
  • Sun G , AlzayadyK , StewartRet al. Histone demethylase LSD1 regulates neural stem cell proliferation . Mol. Cell. Biol.30 ( 8 ), 1997 – 2005 ( 2010 ).
  • Hakimi MA , BocharDA , ChenowethJ , LaneWS , MandelG , ShiekhattarR . A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes . Proc. Natl Acad. Sci. USA99 ( 11 ), 7420 – 7425 ( 2002 ).
  • Ballas N , GrunseichC , LuDD , SpehJC , MandelG . REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis . Cell121 ( 4 ), 645 – 657 ( 2005 ).
  • Fuentes P , CánovasJ , BerndtFA , NoctorSC , KukuljanM . CoREST/LSD1 control the development of pyramidal cortical neurons . Cereb. Cortex22 ( 6 ), 1431 – 1441 ( 2012 ).
  • Chong JX , YuJ-H , LorentzenPet al. Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features . Genet. Med. doi:10.1038/gim.2015.161 ( 2015 ) ( Epub ahead of print ).
  • Maes T , MascaróC , OrtegaAet al. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease . Epigenomics7 ( 4 ), 609 – 626 ( 2015 ).
  • Kim J , SinghAK , TakataYet al. LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice . Nat. Commun.6 , 10116 ( 2015 ).
  • Kerenyi MA , ShaoZ , HsuY-JJet al. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation . Elife2 , e00633 ( 2013 ).
  • Saleque S , KimJ , RookeHM , OrkinSH . Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1 . Mol. Cell27 ( 4 ), 562 – 572 ( 2007 ).
  • Sprussel A , SchulteJH , WeberSet al. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation . Leukemia26 ( 9 ), 2039 – 2051 ( 2012 ).
  • Jarriault S , GreenwaldI . Suppressors of the egg-laying defective phenotype of sel-12 presenilin mutants implicate the CoREST corepressor complex in LIN-12/Notch signaling in C. elegans . Genes Dev.16 ( 20 ), 2713 – 2728 ( 2002 ).
  • Eimer S , LakowskiB , DonhauserR , BaumeisterR . Loss of spr-5 bypasses the requirement for the C. elegans presenilin sel-12 by derepressing hop-1 . EMBO J.21 ( 21 ), 5787 – 5796 ( 2002 ).
  • Katz DJ , EdwardsTM , ReinkeV , KellyWG . A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory . Cell137 ( 2 ), 308 – 320 ( 2009 ).
  • Lan F , ZaratieguiM , VillénJet al. S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription . Mol. Cell26 ( 1 ), 89 – 101 ( 2007 ).
  • Rudolph T , YonezawaM , LeinSet al. Heterochromatin formation in Drosophila is initiated through active removal of H3K4 methylation by the LSD1 homolog SU(VAR)3-3 . Mol. Cell26 ( 1 ), 103 – 115 ( 2007 ).
  • Eliazer S , PalaciosV , WangZ , KolliparaRK , KittlerR , BuszczakM . Lsd1 restricts the number of germline stem cells by regulating multiple targets in escort cells . PLoS Genet.10 ( 3 ), e1004200 ( 2014 ).
  • Mosammaparast N , KimH , LaurentBet al. The histone demethylase LSD1/KDM1A promotes the DNA damage response . J. Cell Biol.203 ( 3 ), 457 – 470 ( 2013 ).
  • Nam HJ , BooK , KimDet al. Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resetting . Mol. Cell53 ( 5 ), 791 – 805 ( 2014 ).
  • Hino S , SakamotoA , NagaokaKet al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure . Nat. Commun.3 , 758 ( 2012 ).
  • Sakamoto A , HinoS , NagaokaKet al. Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells . Cancer Res.75 ( 7 ), 1445 – 1456 ( 2015 ).
  • Su S-T , YingH-Y , ChiuY-K , LinF-R , ChenM-Y , LinK-I . Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation . Mol. Cell. Biol.29 ( 6 ), 1421 – 1431 ( 2009 ).
  • Hu X , LiX , ValverdeKet al. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis . Proc. Natl Acad. Sci. USA106 ( 25 ), 10141 – 10146 ( 2009 ).
  • Mendenhall EM , WilliamsonKE , ReyonDet al. Locus-specific editing of histone modifications at endogenous enhancers . Nat. Biotechnol.31 ( 12 ), 1133 – 1136 ( 2013 ).
  • Kearns NA , PhamH , TabakBet al. Functional annotation of native enhancers with a Cas9-histone demethylase fusion . Nat. Methods12 ( 5 ), 401 – 403 ( 2015 ).
  • Lin Y , WuY , LiJet al. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1 . EMBO J.29 ( 11 ), 1803 – 1816 ( 2010 ).
  • Ferrari-Amorotti G , FragliassoV , EstekiRet al. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion . Cancer Res.73 ( 1 ), 235 – 245 ( 2013 ).
  • Welcker JE , Hernandez-MirandaLR , PaulFEet al. Insm1 controls development of pituitary endocrine cells and requires a SNAG domain for function and for recruitment of histone-modifying factors . Development140 ( 24 ), 4947 – 4958 ( 2013 ).
  • Lin T , PonnA , HuX , LawBK , LuJ . Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial–mesenchymal transition . Oncogene29 ( 35 ), 4896 – 4904 ( 2010 ).
  • Garcia-Bassets I , KwonY-S , TeleseFet al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors . Cell128 ( 3 ), 505 – 518 ( 2007 ).
  • Whyte WA , BilodeauS , OrlandoDAet al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation . Nature482 ( 7384 ), 221 – 225 ( 2012 ).
  • Lara-Astiaso D , WeinerA , Lorenzo-VivasEet al. Chromatin state dynamics during blood formation . Science345 ( 6199 ), 943 – 949 ( 2014 ).
  • Calo E , WysockaJ . Modification of enhancer chromatin: what, how, and why?Mol. Cell49 ( 5 ), 825 – 837 ( 2013 ).
  • Zaret KS , CarrollJS . Pioneer transcription factors: establishing competence for gene expression . Genes Dev.25 ( 21 ), 2227 – 2241 ( 2011 ).
  • Cai C , HeHH , GaoSet al. Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity . Cell Rep.9 ( 5 ), 1618 – 1627 ( 2014 ).
  • Zibetti C , AdamoA , BindaCet al. Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system . J. Neurosci.30 ( 7 ), 2521 – 2532 ( 2010 ).
  • Laurent B , RuituL , MurnJet al. A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation . Mol. Cell57 ( 6 ), 957 – 970 ( 2015 ).
  • Wang J , TeleseF , TanYet al. LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control . Nat. Neurosci.18 ( 9 ), 1256 – 1264 ( 2015 ).
  • Toffolo E , RusconiF , PaganiniLet al. Phosphorylation of neuronal lysine-specific demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2 . J. Neurochem.128 ( 5 ), 603 – 616 ( 2014 ).
  • Lee MG , WynderC , SchmidtDM , McCaffertyDG , ShiekhattarR . Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications . Chem. Biol.13 ( 6 ), 563 – 567 ( 2006 ).
  • Schmidt DMZ , McCaffertyDG . Trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1 . Biochemistry46 ( 14 ), 4408 – 4416 ( 2007 ).
  • Zheng Y-C , MaJ , WangZet al. A systematic review of histone lysine-specific demethylase 1 and its inhibitors . Med. Res. Rev.35 ( 5 ), 1032 – 1071 ( 2015 ).
  • Mould DP , McGonagleAE , WisemanDH , WilliamsEL , JordanAM . Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date . Med. Res. Rev.35 ( 3 ), 586 – 618 ( 2015 ).
  • Harris WJ , HuangX , LynchJTet al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells . Cancer Cell21 ( 4 ), 473 – 487 ( 2012 ).
  • Mohammad HP , SmithemanKN , KamatCDet al. A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC . Cancer Cell28 ( 1 ), 57 – 69 ( 2015 ).
  • Cui S , LimK-C , ShiLet al. The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice . Blood126 ( 3 ), 386 – 396 ( 2015 ).
  • Sankar S , TheisenER , BearssJet al. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth . Clin. Cancer Res.20 ( 17 ), 4584 – 4597 ( 2014 ).
  • Schmitt ML , HauserA-T , CarlinoLet al. Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity . J. Med. Chem.56 ( 18 ), 7334 – 7342 ( 2013 ).
  • Wang J , LuF , RenQet al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties . Cancer Res.71 ( 23 ), 7238 – 7249 ( 2011 ).
  • Zhang X , LuF , WangJet al. Pluripotent stem cell protein Sox2 confers sensitivity to LSD1 inhibition in cancer cells . Cell Rep.5 ( 2 ), 445 – 457 ( 2013 ).
  • Hitchin JR , BlaggJ , BurkeRet al. Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments . MedChemComm4 ( 11 ), 1513 ( 2013 ).
  • Culhane JC , SzewczukLM , LiuX , DaG , MarmorsteinR , ColePA . A mechanism-based inactivator for histone demethylase LSD1 . J. Am. Chem. Soc.128 ( 14 ), 4536 – 4537 ( 2006 ).
  • Kumarasinghe IR , WosterPM . Synthesis and evaluation of novel cyclic peptide inhibitors of lysine-specific demethylase 1 . ACS Med. Chem. Lett.5 ( 1 ), 29 – 33 ( 2014 ).
  • Murray-Stewart T , WosterPM , CaseroRA . The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines . Amino Acids46 ( 3 ), 585 – 594 ( 2014 ).
  • Hazeldine S , PachaiyappanB , SteinbergsNet al. Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1 . J. Med. Chem.55 ( 17 ), 7378 – 7391 ( 2012 ).
  • McGrath JP , WilliamsonKE , BalasubramanianSet al. Pharmacological inhibition of the histone lysine demethylase KDM1A suppresses the growth of multiple acute myeloid leukemia subtypes . Cancer Res.76 ( 7 ), 1975 – 1988 ( 2016 ).
  • Fiskus W , SharmaS , ShahBet al. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells . Leukemia28 ( 11 ), 2155 – 2164 ( 2014 ).
  • Kahl P , GullottiL , HeukampLCet al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence . Cancer Res.66 ( 23 ), 11341 – 11347 ( 2006 ).
  • Schulte JH , LimS , SchrammAet al. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy . Cancer Res.69 ( 5 ), 2065 – 2071 ( 2009 ).
  • Lim S , JanzerA , BeckerAet al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology . Carcinogenesis31 ( 3 ), 512 – 520 ( 2010 ).
  • Shi L , CuiS , EngelJD , TanabeO . Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction . Nat. Med.19 ( 3 ), 291 – 294 ( 2013 ).
  • Liang Y , VogelJL , NarayananA , PengH , KristieTM . Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency . Nat. Med.15 ( 11 ), 1312 – 1317 ( 2009 ).
  • Binda C , ValenteS , RomanenghiMet al. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2 . J. Am. Chem. Soc.132 ( 19 ), 6827 – 6833 ( 2010 ).
  • Schenk T , ChenWC , GollnerSet al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia . Nat. Med.18 ( 4 ), 605 – 611 ( 2012 ).
  • Singh MM , JohnsonB , VenkatarayanAet al. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma . Neuro. Oncol.17 ( 11 ), 1463 – 1473 ( 2015 ).
  • McGrath JP , WilliamsonKE , BalasubramanianSet al. Pharmacological inhibition of the histone lysine demethylase KDM1A suppresses the growth of multiple acute myeloid leukemia subtypes . Cancer Res.76 ( 7 ), 1975 – 1982 ( 2016 ).
  • Tomita N , KajiiS , CaryDRet al. WO 2013/022047 AI ( 2013 ).
  • McCall JM , ReinhoffHYJr , ClareM . Patent WO 2015021128 A1 ( 2015 ).
  • Incyte Corporation , WO2015123437 ( 2015 ).
  • The Board of Regents of the Nevada System of Higher Education . WO2014194280 ( 2014 ).
  • Epitherapeutics Aps . US9221801 ( 2015 ).
  • Quanticel Pharmaceuticals . WO2015168466 A1 ( 2015 ).